← Leaderboards
Mark A Smith
Case Western Reserve University
$2,639,756
Attributed
$2,729,756
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $513.2K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,729,756 · 6
By mechanism
R01$1,953,668 · 3
R21$357,204 · 1
P01$283,884 · 1
R13$135,000 · 1
Top collaborators
- Sherman Mitchell Harman3 shared
- Janko Nikolich-Zugich3 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Fabio Cominelli$30,550,057
- Laura E. Nagy$35,655,521
- Jianjie Ma$31,916,684
- Bruce T Lamb$28,978,707
- Theresa Torres Pizarro$21,932,219
Others in their field
Top investigators on “Immunocytochemistry”
- Anthony N Van Den Pol · Yale University$15,503,444
- Fred H Gage · Brown University$13,660,280
- Hongjun Song · Johns Hopkins University$12,462,321
- Muhammad Ashraf · University Of Cincinnati$12,412,642
- Eliezer Masliah · University Of California San Diego$12,284,679
- Eric Klann · University Of Pittsburgh At Pittsburgh$9,943,789
Research focus
ImmunocytochemistryProteinsNeuropathologyAlzheimer&AposHuman TissueBaseCellsBrainLeadAffectGenerationsAmyloidS DiseaseSeriesPathogenesisAnimalsPreventGliosisMalignant NeoplasmsCognitive DeficitsDepositionCell Cycle ProteinsCell CycleCell Cycle Regulation
Grant awards (16)
Annual Meeting of the American Aging Association$45,000
R13 · FY2011 · AG
Annual Meeting of the American Aging Association$45,000
R13 · FY2010 · AG
Role of Cell Cycle in Neurodegeneration$321,850
R01 · FY2009 · AG · contact PI
Annual Meeting of the American Aging Association$45,000
R13 · FY2009 · AG
Role of Cell Cycle in Neurodegeneration$320,141
R01 · FY2008 · AG · contact PI
Cell Cycle Inhibitors in Alzheimer Disease$193,048
R21 · FY2008 · AG · contact PI
Amyloid-beta: The Alternate Hypothesis$240,251
R01 · FY2007 · AG · contact PI
Cell Cycle Inhibitors in Alzheimer Disease$164,156
R21 · FY2007 · AG · contact PI
Amyloid-beta: The Alternate Hypothesis$247,426
R01 · FY2006 · AG · contact PI
Amyloid-beta: The Alternate Hypothesis$253,380
R01 · FY2005 · AG
METABOLIC ABNORMALITIES IN ALZHEIMER DISEASE$194,405
R01 · FY2002 · NS
Core--Morphology and immunohistochemistry facility$94,628
P01 · FY2002 · DK
METABOLIC ABNORMALITIES IN ALZHEIMER DISEASE$188,666
R01 · FY2001 · NS
Core--Morphology and immunohistochemistry facility$94,628
P01 · FY2001 · DK
METABOLIC ABNORMALITIES IN ALZHEIMER DISEASE$187,549
R01 · FY2000 · NS
Core--Morphology and immunohistochemistry facility$94,628
P01 · FY2000 · DK